BRIEF-Telix Pharmaceuticals Limited Reports Qtrly Group Revenue Of $245 Million

2

Oct 21 (Reuters) – Telix Pharmaceuticals Limited : * QTRLY GROUP REVENUE OF US$245 MILLION * REAFFIRMED THAT FY 2026 REVENUE AND OTHER INCOME IS EXPECTED TO BE IN EXCESS OF US$1 BILLION * REVENUE

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)